BTAIQ · BioXcel Therapeutics, Inc. · Executive Compensation
$0.05
+0.01 (+15.56%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.19M
Shares
31.31M
Volume · Oct 2
347.7K
Avg daily vol (3M)
6.22M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Vimal Mehta | Chief Executive Officer | $1,119,245 |
| Javier Rodriguez | Senior VP and Chief Legal Officer | $1,012,552 |
| Richard Steinhart | SVP and Chief Financial Officer | $998,216 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Vimal Mehta | Chief Executive Officer | $4,731,147 |
| Matthew Wiley | SVP and Chief Commercial Officer | $1,264,394 |
| Javier Rodriguez | Senior VP and Chief Legal Officer | $1,121,943 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Vimal Mehta | Chief Executive Officer | $4,559,195 |
| Matthew Wiley | SVP and Chief Commercial Officer | $1,927,697 |
| Javier Rodriguez | Senior VP and Chief Legal Officer | $1,218,539 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Vimal Mehta | Chief Executive Officer | $9,372,177 |
| Javier Rodriquez | Senior Vice President and Chief Legal Officer | $2,014,426 |
| Javier Rodriguez | Senior VP and Chief Legal Officer | $2,014,426 |
| Frank Yocca | Senior Vice President and Chief Scientific Officer | $1,153,469 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Vimal Mehta | Chief Executive Officer and President | $9,576,550 |
| William P. Kane | Executive Vice President and Chief Commercial Officer | $4,569,654 |
| Reina Benabou | M.D., Ph.D. Senior Vice President and Chief Development Officer | $2,736,184 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Vimal Mehta | Chief Executive Officer and President | $1,968,931 |
| Vincent O’Neill | Chief Medical Officer | $510,167 |
| Richard Steinhart | Chief Financial Officer | $403,997 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Vimal Mehta | President and Chief Executive Officer | $701,609 |
| Vincent O’Neill | Chief Medical Officer | $663,301 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. Rajiv Patni | Class II director | Appointed | 2025-01-16 |
| David Mack | Class I director | Appointed | 2024-11-21 |
| Matthew Wiley | Senior Vice President and Chief Commercial Officer | Resigned | 2024-10-09 |
| Matt Wiley | Chief Commercial Officer | Terminated | 2024-09-19 |
| Krishnan Nandabalan | member of the Company's Board of Directors | Resigned | 2023-09-25 |
| Michael Miller | Class II director | Appointed | 2022-07-05 |